Can a single inflammatory marker adequately predict resistance to erythropoiesis-stimulating agents in hemodialysis patients?

Autor

Eleftheriadis, T.; Antoniadi, G.; Liakopoulos, V.; Stefanidis, I.

Datum

2013

DOI

10.1111/j.1542-4758.2012.00690.x

Schlagwort

DIALYSIS PATIENTS

Urology & Nephrology

Zur Langanzeige

URI

http://hdl.handle.net/11615/27309

Collections

Δημοσιεύσεις σε περιοδικά, συνέδρια, κεφάλαια βιβλίων κλπ. [19735]